Montreux Equity Partners
Montreux Equity Partners, based in Menlo Park, CA, is a life sciences focused venture capital firm that invests in pharmaceutical and medical device companies. Montreux’s goal is to generate significant capital gains for both their investors and the entrepreneurs that they support. Montreux is currently investing out of their fourth fund, MEP IV, a $250 M fund.
Milestones
Investments
Videos
Sources
-
Pivot Medical Raises $32M in Series C Financing (finsmes.com)
[edit]
-
SI-BONE Closes $16.0M Financing Round (finsmes.com)
[edit]
-
GC Aesthetics Secures $30 Million in Financing from Montreux Equity Partners (gcaesthetics.com)
[edit]
-
Tobira Therapeutics Inc. Raises $31 Million in Series B Financing (tobiratherapeutics.com)
[edit]
-
Avantis Medical Systems brings in $2.1M to detect cancer (deals.venturebeat.com)
[edit]
-
Pulmonx, Inc.: Series C $32M (onbiovc.com)
[edit]
-
Glaukos Adds $35 Million (equityhelpdesk.com)
[edit]
-
Lung-device maker Pulmonx draws in $20M (venturebeat.com)
[edit]
-
Insomnia drug company, TransOral, raises $40M more (deals.venturebeat.com)
[edit]
-
Cancer treatment co., Avantis Medical, gets $12M (deals.venturebeat.com)
[edit]